Circulating tumor cells as an independent prognostic factor in advanced colorectal cancer: a retrospective study in 121 patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Circulating tumor cells as an independent prognostic factor in advanced colorectal cancer: a retrospective study in 121 patients

Published:2019-01-10 Issue:4 Volume:34 Page:589-597
ISSN:0179-1958
Container-title:International Journal of Colorectal Disease
language:en
Short-container-title:Int J Colorectal Dis

Author:

Wang Lili,Zhou Shichao,Zhang Wenying,Wang Jiongyi,Wang Meiling,Hu Xiaohua,Liu Feng,Zhang Yanjie,Jiang Bin,Yuan Haihua

Funder

School of Medicine, Shanghai Jiao Tong University

Science and Technology Commission of Shanghai Municipality

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

http://link.springer.com/content/pdf/10.1007/s00384-018-03223-9.pdf

Reference36 articles.

1. Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68(1):7–30. https://doi.org/10.3322/caac.21442

2. Kemeny N (2010) The management of resectable and unresectable liver metastases from colorectal cancer. Curr Opin Oncol 22(4):364–373. https://doi.org/10.1097/CCO.0b013e32833a6c8a

3. Tzeng CW, Aloia TA (2013) Colorectal liver metastases. J Gastrointest Surg 17(1):195–201; quiz p 201–192. https://doi.org/10.1007/s11605-012-2022-3

4. Liu Y, Luan L, Wang X (2015) A randomized phase II clinical study of combining panitumumab and bevacizumab, plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) compared with FOLFIRI alone as second-line treatment for patients with metastatic colorectal cancer and KRAS mutation. OncoTargets Therapy 8:1061–1068. https://doi.org/10.2147/OTT.S81442

5. Cao R, Zhang S, Ma D, Hu L (2015) A multi-center randomized phase II clinical study of bevacizumab plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) compared with FOLFIRI alone as second-line treatment for Chinese patients with metastatic colorectal cancer. Med Oncol 32(1):325. https://doi.org/10.1007/s12032-014-0325-9

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the impact of circulating tumor cells: Two decades of discovery and clinical advancements in solid tumors;Critical Reviews in Oncology/Hematology;2024-11

2. Circulating Tumor Cells: Pathological, Molecular and Functional Characteristics;International Journal of Molecular Sciences;2024-07-27

3. Unique Cohorts of Salivary Gland Cancer Cells as an in-vitro Model of Circulating Tumor Cells;Journal of Maxillofacial and Oral Surgery;2024-06-16

4. Prospects of liquid biopsy in the prognosis and clinical management of gastrointestinal cancers;Frontiers in Molecular Biosciences;2024-05-06

5. Investigating the role of circulating tumor cells in gastric cancer: a comprehensive systematic review and meta-analysis;Clinical and Experimental Medicine;2024-03-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3